{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T19:23:08Z","timestamp":1788895388739,"version":"build-2803163510"},"reference-count":108,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pediatric Clinics of North America"],"published-print":{"date-parts":[[2012,4]]},"DOI":"10.1016\/j.pcl.2012.03.014","type":"journal-article","created":{"date-parts":[[2012,5,4]],"date-time":"2012-05-04T06:49:55Z","timestamp":1336114195000},"page":"301-327","source":"Crossref","is-referenced-by-count":97,"title":["Juvenile Idiopathic Arthritis"],"prefix":"10.1016","volume":"59","author":[{"given":"Peter J.","family":"Gowdie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shirley M.L.","family":"Tse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pcl.2012.03.014_bib1","series-title":"Textbook of pediatric rheumatology","author":"Cassidy","year":"2011"},{"issue":"7","key":"10.1016\/j.pcl.2012.03.014_bib2","first-page":"1520","article-title":"Worldwide prevalence of juvenile arthritis why does it vary so much?","volume":"29","author":"Manners","year":"2002","journal-title":"J\u00a0Rheumatol"},{"issue":"1","key":"10.1016\/j.pcl.2012.03.014_bib3","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1542\/peds.98.1.84","article-title":"Prevalence of juvenile chronic arthritis in a population of 12-year-old children in urban Australia","volume":"98","author":"Manners","year":"1996","journal-title":"Pediatrics"},{"issue":"5","key":"10.1016\/j.pcl.2012.03.014_bib4","first-page":"563","article-title":"Prevalence of inflammatory rheumatic diseases in an adolescent urban student population, age 12 to 18, in Belgium","volume":"11","author":"Mielants","year":"1993","journal-title":"Clin Exp Rheumatol"},{"issue":"5\u20136","key":"10.1016\/j.pcl.2012.03.014_bib5","first-page":"529","article-title":"Prevalence of juvenile chronic arthritis in school children aged 10 to 15 years in Alexandria","volume":"74","author":"Tayel","year":"1999","journal-title":"J\u00a0Egypt Public Health Assoc"},{"issue":"7","key":"10.1016\/j.pcl.2012.03.014_bib6","first-page":"1356","article-title":"Frequency of uncommon diseases: is juvenile idiopathic arthritis underrecognized?","volume":"29","author":"Petty","year":"2002","journal-title":"J\u00a0Rheumatol"},{"issue":"1","key":"10.1016\/j.pcl.2012.03.014_bib7","first-page":"174","article-title":"A\u00a0prospective population based study on outcome of juvenile chronic arthritis in Costa Rica","volume":"29","author":"Arguedas","year":"2002","journal-title":"J\u00a0Rheumatol"},{"issue":"9","key":"10.1016\/j.pcl.2012.03.014_bib8","first-page":"1844","article-title":"Juvenile chronic arthritis in urban San Jose, Costa Rica: a 2 year prospective study","volume":"25","author":"Arguedas","year":"1998","journal-title":"J\u00a0Rheumatol"},{"issue":"2","key":"10.1016\/j.pcl.2012.03.014_bib9","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1111\/j.1442-200X.1997.tb03592.x","article-title":"A\u00a0nationwide surveillance study of rheumatic diseases among Japanese children","volume":"39","author":"Fujikawa","year":"1997","journal-title":"Acta Paediatr Jpn"},{"issue":"2","key":"10.1016\/j.pcl.2012.03.014_bib10","first-page":"379","article-title":"Ethnic differences in risk for pediatric rheumatic illness in a culturally diverse population","volume":"29","author":"Kurahara","year":"2002","journal-title":"J\u00a0Rheumatol"},{"issue":"6","key":"10.1016\/j.pcl.2012.03.014_bib11","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1002\/art.22709","article-title":"Epidemiology of juvenile idiopathic arthritis in a multiethnic cohort: ethnicity as a risk factor","volume":"56","author":"Saurenmann","year":"2007","journal-title":"Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.pcl.2012.03.014_bib12","first-page":"390","article-title":"International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001","volume":"31","author":"Petty","year":"2004","journal-title":"J\u00a0Rheumatol"},{"issue":"10","key":"10.1016\/j.pcl.2012.03.014_bib13","first-page":"1991","article-title":"Revision of the proposed classification criteria for juvenile idiopathic arthritis: Durban, 1997","volume":"25","author":"Petty","year":"1998","journal-title":"J\u00a0Rheumatol"},{"issue":"1","key":"10.1016\/j.pcl.2012.03.014_bib14","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/0167-5273(92)90082-E","article-title":"Symptomatic cardiac involvement in juvenile rheumatoid arthritis","volume":"34","author":"Goldenberg","year":"1992","journal-title":"Int J Cardiol"},{"issue":"1","key":"10.1016\/j.pcl.2012.03.014_bib15","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0022-3476(99)70372-0","article-title":"Malignancies in children who initially present with rheumatic complaints","volume":"134","author":"Cabral","year":"1999","journal-title":"J\u00a0Pediatr"},{"issue":"4","key":"10.1016\/j.pcl.2012.03.014_bib16","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/S0022-3476(05)83543-7","article-title":"Differentiation of systemic juvenile rheumatoid arthritis from acute leukemia near the onset of disease","volume":"122","author":"Ostrov","year":"1993","journal-title":"J\u00a0Pediatr"},{"issue":"4","key":"10.1016\/j.pcl.2012.03.014_bib17","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/S0022-3476(72)80108-2","article-title":"Arthritis as a presenting manifestation of malignancy in children","volume":"81","author":"Schaller","year":"1972","journal-title":"J\u00a0Pediatr"},{"issue":"5","key":"10.1016\/j.pcl.2012.03.014_bib18","doi-asserted-by":"crossref","first-page":"e840","DOI":"10.1542\/peds.2005-1515","article-title":"A\u00a0multicenter case-control study on predictive factors distinguishing childhood leukemia from juvenile rheumatoid arthritis","volume":"117","author":"Jones","year":"2006","journal-title":"Pediatrics"},{"issue":"2 Pt 1","key":"10.1016\/j.pcl.2012.03.014_bib19","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/S0022-3476(05)80427-5","article-title":"Prognostic indicators of joint destruction in systemic-onset juvenile rheumatoid arthritis","volume":"120","author":"Schneider","year":"1992","journal-title":"J\u00a0Pediatr"},{"issue":"11","key":"10.1016\/j.pcl.2012.03.014_bib20","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1002\/1529-0131(200011)43:11<2402::AID-ANR5>3.0.CO;2-C","article-title":"Early predictors of poor functional outcome in systemic-onset juvenile rheumatoid arthritis: a multicenter cohort study","volume":"43","author":"Spiegel","year":"2000","journal-title":"Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.pcl.2012.03.014_bib21","first-page":"211","article-title":"Systemic onset juvenile chronic arthritis, polyarticular pattern and hip involvement as markers for a bad prognosis","volume":"19","author":"Modesto","year":"2001","journal-title":"Clin Exp Rheumatol"},{"issue":"5","key":"10.1016\/j.pcl.2012.03.014_bib22","first-page":"1133","article-title":"Occult macrophage activation syndrome in patients with systemic juvenile idiopathic arthritis","volume":"34","author":"Behrens","year":"2007","journal-title":"J\u00a0Rheumatol"},{"issue":"5","key":"10.1016\/j.pcl.2012.03.014_bib23","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.jpeds.2004.12.016","article-title":"Preliminary diagnostic guidelines for macrophage activation syndrome complicating systemic juvenile idiopathic arthritis","volume":"146","author":"Ravelli","year":"2005","journal-title":"J\u00a0Pediatr"},{"issue":"11","key":"10.1016\/j.pcl.2012.03.014_bib24","doi-asserted-by":"crossref","first-page":"3564","DOI":"10.1002\/art.22173","article-title":"Patients with juvenile psoriatic arthritis comprise two distinct populations","volume":"54","author":"Stoll","year":"2006","journal-title":"Arthritis Rheum"},{"issue":"5","key":"10.1016\/j.pcl.2012.03.014_bib25","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1097\/BOR.0b013e328348b278","article-title":"Psoriatic juvenile idiopathic arthritis: a tale of two subgroups","volume":"23","author":"Stoll","year":"2011","journal-title":"Curr Opin Rheumatol"},{"issue":"5","key":"10.1016\/j.pcl.2012.03.014_bib26","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1542\/peds.2006-0421","article-title":"American Academy of Pediatrics Section on Rheumatology and Section on Ophthalmology: opthalmologic examination in children with juvenile rheumatoid arthritis","volume":"117","year":"2006","journal-title":"Pediatrics"},{"issue":"10","key":"10.1016\/j.pcl.2012.03.014_bib27","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1016\/S0161-6420(84)34177-X","article-title":"Systemic uveitis syndromes in childhood: an analysis of 340 cases","volume":"91","author":"Kanski","year":"1984","journal-title":"Ophthalmology"},{"issue":"5","key":"10.1016\/j.pcl.2012.03.014_bib28","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.ghir.2008.01.006","article-title":"Inflammatory cytokines in juvenile idiopathic arthritis: effects on physical growth and the insulin-like-growth factor axis","volume":"18","author":"Wong","year":"2008","journal-title":"Growth Horm IGF Res"},{"issue":"2","key":"10.1016\/j.pcl.2012.03.014_bib29","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1002\/art.1780400218","article-title":"Juvenile rheumatoid arthritis. Effects of disease activity and recombinant human growth hormone on insulin-like growth factor 1, insulin-like growth factor binding proteins 1 and 3, and osteocalcin","volume":"40","author":"Davies","year":"1997","journal-title":"Arthritis Rheum"},{"issue":"Suppl 1","key":"10.1016\/j.pcl.2012.03.014_bib30","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1159\/000229760","article-title":"The impact of chronic inflammation on the growing skeleton: lessons from interleukin-6 transgenic mice","volume":"72","author":"De Benedetti","year":"2009","journal-title":"Horm Res"},{"issue":"7","key":"10.1016\/j.pcl.2012.03.014_bib31","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1093\/rheumatology\/kep460","article-title":"BSPAR Standards of Care for children and young people with juvenile idiopathic arthritis","volume":"49","author":"Davies","year":"2010","journal-title":"Rheumatology (Oxford)"},{"issue":"7","key":"10.1016\/j.pcl.2012.03.014_bib32","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1002\/art.21956","article-title":"A\u00a0randomized controlled trial of calcium supplementation to increase bone mineral density in children with juvenile rheumatoid arthritis","volume":"54","author":"Lovell","year":"2006","journal-title":"Arthritis Rheum"},{"issue":"7","key":"10.1016\/j.pcl.2012.03.014_bib33","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1002\/art.23008","article-title":"The effects of vigorous exercise training on physical function in children with arthritis: a randomized, controlled, single-blinded trial","volume":"57","author":"Singh-Grewal","year":"2007","journal-title":"Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.pcl.2012.03.014_bib34","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1080\/03009740310002524","article-title":"Relationship between functional ability and physical fitness in juvenile idiopathic arthritis patients","volume":"32","author":"Takken","year":"2003","journal-title":"Scand J Rheumatol"},{"issue":"9","key":"10.1016\/j.pcl.2012.03.014_bib35","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1136\/ard.62.9.885","article-title":"Physical activity and health related physical fitness in children with juvenile idiopathic arthritis","volume":"62","author":"Takken","year":"2003","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"10.1016\/j.pcl.2012.03.014_bib36","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1093\/rheumatology\/keg386","article-title":"Aquatic fitness training for children with juvenile idiopathic arthritis","volume":"42","author":"Takken","year":"2003","journal-title":"Rheumatology (Oxford)"},{"issue":"5","key":"10.1016\/j.pcl.2012.03.014_bib37","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/S0031-3955(16)40055-6","article-title":"Drug treatment in children with juvenile rheumatoid arthritis. Past, present, and future","volume":"42","author":"Giannini","year":"1995","journal-title":"Pediatr Clin North Am"},{"issue":"12","key":"10.1016\/j.pcl.2012.03.014_bib38","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1002\/art.1780271216","article-title":"Time course of response to nonsteroidal antiinflammatory drugs in juvenile rheumatoid arthritis","volume":"27","author":"Lovell","year":"1984","journal-title":"Arthritis Rheum"},{"issue":"6","key":"10.1016\/j.pcl.2012.03.014_bib39","first-page":"1149","article-title":"Clinically significant gastropathy associated with nonsteroidal antiinflammatory drug use in children with juvenile rheumatoid arthritis","volume":"22","author":"Keenan","year":"1995","journal-title":"J\u00a0Rheumatol"},{"issue":"9","key":"10.1016\/j.pcl.2012.03.014_bib40","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1002\/art.1780380908","article-title":"Nonsteroidal antiinflammatory drug-induced gastroduodenal injury in children","volume":"38","author":"Dowd","year":"1995","journal-title":"Arthritis Rheum"},{"issue":"9","key":"10.1016\/j.pcl.2012.03.014_bib41","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1093\/rheumatology\/ker165","article-title":"Outcome and predicting factors of single and multiple intra-articular corticosteroid injections in children with juvenile idiopathic arthritis","volume":"50","author":"Lanni","year":"2011","journal-title":"Rheumatology (Oxford)"},{"issue":"4","key":"10.1016\/j.pcl.2012.03.014_bib42","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s00431-007-0525-9","article-title":"Factors influencing the efficacy of intra-articular steroid injections in patients with juvenile idiopathic arthritis","volume":"167","author":"Marti","year":"2008","journal-title":"Eur J Pediatr"},{"issue":"10","key":"10.1016\/j.pcl.2012.03.014_bib43","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1093\/rheumatology\/keh313","article-title":"Triamcinolone acetonide and hexacetonide intra-articular treatment of symmetrical joints in juvenile idiopathic arthritis: a double-blind trial","volume":"43","author":"Zulian","year":"2004","journal-title":"Rheumatology (Oxford)"},{"issue":"5","key":"10.1016\/j.pcl.2012.03.014_bib44","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1093\/rheumatology\/33.5.464","article-title":"A\u00a0randomized controlled study of post-injection rest following intra-articular steroid therapy for knee synovitis","volume":"33","author":"Chakravarty","year":"1994","journal-title":"Br J Rheumatol"},{"key":"10.1016\/j.pcl.2012.03.014_bib45","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD002824.pub2","article-title":"Intra-articular steroids and splints\/rest for children with juvenile idiopathic arthritis and adults with rheumatoid arthritis","volume":"1","author":"Wallen","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"issue":"16","key":"10.1016\/j.pcl.2012.03.014_bib46","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1056\/NEJM199204163261602","article-title":"Methotrexate in resistant juvenile rheumatoid arthritis. Results of the U.S.A.-U.S.S.R. double-blind, placebo-controlled trial. The Pediatric Rheumatology Collaborative Study Group and The Cooperative Children's Study Group","volume":"326","author":"Giannini","year":"1992","journal-title":"N\u00a0Engl J Med"},{"issue":"8","key":"10.1016\/j.pcl.2012.03.014_bib47","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1002\/1529-0131(200008)43:8<1849::AID-ANR22>3.0.CO;2-F","article-title":"Randomized, placebo-controlled, crossover trial of low-dose oral methotrexate in children with extended oligoarticular or systemic arthritis","volume":"43","author":"Woo","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.pcl.2012.03.014_bib48","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD003129","article-title":"Methotrexate for treating juvenile idiopathic arthritis","volume":"4","author":"Takken","year":"2001","journal-title":"Cochrane Database Syst Rev"},{"issue":"7","key":"10.1016\/j.pcl.2012.03.014_bib49","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1002\/art.20288","article-title":"A\u00a0randomized trial of parenteral methotrexate comparing an intermediate dose with a higher dose in children with juvenile idiopathic arthritis who failed to respond to standard doses of methotrexate","volume":"50","author":"Ruperto","year":"2004","journal-title":"Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.pcl.2012.03.014_bib50","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/S0022-3476(99)70127-7","article-title":"The extended oligoarticular subtype is the best predictor of methotrexate efficacy in juvenile idiopathic arthritis","volume":"135","author":"Ravelli","year":"1999","journal-title":"J\u00a0Pediatr"},{"issue":"6","key":"10.1016\/j.pcl.2012.03.014_bib51","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1542\/peds.100.6.994","article-title":"Discontinuation of methotrexate treatment in juvenile rheumatoid arthritis","volume":"100","author":"Gottlieb","year":"1997","journal-title":"Pediatrics"},{"issue":"13","key":"10.1016\/j.pcl.2012.03.014_bib52","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1001\/jama.2010.375","article-title":"Methotrexate withdrawal at 6 vs 12 months in juvenile idiopathic arthritis in remission: a randomized clinical trial","volume":"303","author":"Foell","year":"2010","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.pcl.2012.03.014_bib53","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/S0889-857X(05)70362-8","article-title":"Methotrexate in the treatment of juvenile rheumatoid arthritis and other pediatric rheumatoid and nonrheumatic disorders","volume":"23","author":"Singsen","year":"1997","journal-title":"Rheum Dis Clin North Am"},{"issue":"16","key":"10.1016\/j.pcl.2012.03.014_bib54","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1056\/NEJMoa041810","article-title":"Leflunomide or methotrexate for juvenile rheumatoid arthritis","volume":"352","author":"Silverman","year":"2005","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.pcl.2012.03.014_bib55","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.rdc.2004.01.010","article-title":"Leflunomide","volume":"30","author":"Cannon","year":"2004","journal-title":"Rheum Dis Clin North Am"},{"issue":"5","key":"10.1016\/j.pcl.2012.03.014_bib56","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1002\/1529-0131(199805)41:5<808::AID-ART6>3.0.CO;2-T","article-title":"Sulfasalazine in the treatment of juvenile chronic arthritis: a randomized, double-blind, placebo-controlled, multicenter study. Dutch Juvenile Chronic Arthritis Study Group","volume":"41","author":"van Rossum","year":"1998","journal-title":"Arthritis Rheum"},{"issue":"10","key":"10.1016\/j.pcl.2012.03.014_bib57","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1136\/ard.61.10.941","article-title":"A\u00a026 week randomised, double blind, placebo controlled exploratory study of sulfasalazine in juvenile onset spondyloarthropathies","volume":"61","author":"Burgos-Vargas","year":"2002","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.pcl.2012.03.014_bib58","first-page":"360","article-title":"Sulfasalazine therapy for juvenile rheumatoid arthritis","volume":"23","author":"Imundo","year":"1996","journal-title":"J\u00a0Rheumatol"},{"issue":"6","key":"10.1016\/j.pcl.2012.03.014_bib59","first-page":"880","article-title":"Sulfasalazine treatment in juvenile chronic arthritis: an open study","volume":"18","author":"Joos","year":"1991","journal-title":"J\u00a0Rheumatol"},{"issue":"1","key":"10.1016\/j.pcl.2012.03.014_bib60","first-page":"124","article-title":"Sulphasalazine in the treatment of juvenile rheumatoid arthritis: a preliminary open trial","volume":"13","author":"Ozdogan","year":"1986","journal-title":"J\u00a0Rheumatol"},{"issue":"4","key":"10.1016\/j.pcl.2012.03.014_bib61","first-page":"845","article-title":"Sulfasalazine for the management of juvenile rheumatoid arthritis","volume":"28","author":"Brooks","year":"2001","journal-title":"J\u00a0Rheumatol"},{"issue":"5","key":"10.1016\/j.pcl.2012.03.014_bib62","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1093\/rheumatology\/29.5.407","article-title":"Neutropenia in patients with rheumatoid arthritis, treated with sulphasalazine","volume":"29","author":"Marouf","year":"1990","journal-title":"Br J Rheumatol"},{"issue":"4","key":"10.1016\/j.pcl.2012.03.014_bib63","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1136\/ard.55.4.243","article-title":"Serum p55 and p75 tumour necrosis factor receptors as markers of disease activity in juvenile chronic arthritis","volume":"55","author":"Gattorno","year":"1996","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"10.1016\/j.pcl.2012.03.014_bib64","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1089\/107999099313217","article-title":"Long-term follow-up of cytokines and soluble cytokine receptors in peripheral blood of patients with juvenile rheumatoid arthritis","volume":"19","author":"Mangge","year":"1999","journal-title":"J\u00a0Interferon Cytokine Res"},{"issue":"11","key":"10.1016\/j.pcl.2012.03.014_bib65","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1056\/NEJM200003163421103","article-title":"Etanercept in children with polyarticular juvenile rheumatoid arthritis. Pediatric Rheumatology Collaborative Study Group","volume":"342","author":"Lovell","year":"2000","journal-title":"N\u00a0Engl J Med"},{"issue":"8","key":"10.1016\/j.pcl.2012.03.014_bib66","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1093\/rheumatology\/kep122","article-title":"Safety and efficacy of once weekly etanercept 0.8 mg\/kg in a multicentre 12 week trial in active polyarticular course juvenile idiopathic arthritis","volume":"48","author":"Horneff","year":"2009","journal-title":"Rheumatology (Oxford)"},{"issue":"5","key":"10.1016\/j.pcl.2012.03.014_bib67","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1136\/ard.2006.067629","article-title":"Effectiveness of a once weekly double dose of etanercept in patients with juvenile idiopathic arthritis: a clinical study","volume":"66","author":"Prince","year":"2007","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"10.1016\/j.pcl.2012.03.014_bib68","doi-asserted-by":"crossref","first-page":"2794","DOI":"10.1002\/art.24777","article-title":"Long-term safety and effectiveness of etanercept in children with selected categories of juvenile idiopathic arthritis","volume":"60","author":"Giannini","year":"2009","journal-title":"Arthritis Rheum"},{"issue":"5","key":"10.1016\/j.pcl.2012.03.014_bib69","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1002\/art.23427","article-title":"Safety and efficacy of up to eight years of continuous etanercept therapy in patients with juvenile rheumatoid arthritis","volume":"58","author":"Lovell","year":"2008","journal-title":"Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.pcl.2012.03.014_bib70","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s00296-009-0942-3","article-title":"Improvement of functional ability in children with juvenile idiopathic arthritis by treatment with etanercept","volume":"30","author":"Halbig","year":"2009","journal-title":"Rheumatol Int"},{"issue":"1","key":"10.1016\/j.pcl.2012.03.014_bib71","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1136\/ard.2009.111260","article-title":"Major improvements in health-related quality of life during the use of etanercept in patients with previously refractory juvenile idiopathic arthritis","volume":"69","author":"Prince","year":"2010","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"10.1016\/j.pcl.2012.03.014_bib72","first-page":"545","article-title":"Use of infliximab in patients with systemic juvenile idiopathic arthritis refractory to etanercept","volume":"23","author":"Katsicas","year":"2005","journal-title":"Clin Exp Rheumatol"},{"issue":"5","key":"10.1016\/j.pcl.2012.03.014_bib73","first-page":"935","article-title":"Etanercept treatment in patients with refractory systemic onset juvenile rheumatoid arthritis","volume":"32","author":"Kimura","year":"2005","journal-title":"J\u00a0Rheumatol"},{"issue":"5","key":"10.1016\/j.pcl.2012.03.014_bib74","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1136\/ard.2007.087411","article-title":"Long-term follow-up on effectiveness and safety of etanercept in juvenile idiopathic arthritis: the Dutch national register","volume":"68","author":"Prince","year":"2009","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"10.1016\/j.pcl.2012.03.014_bib75","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1002\/art.10885","article-title":"Efficacy of etanercept for the treatment of juvenile idiopathic arthritis according to the onset type","volume":"48","author":"Quartier","year":"2003","journal-title":"Arthritis Rheum"},{"issue":"10","key":"10.1016\/j.pcl.2012.03.014_bib76","first-page":"2055","article-title":"Prolonged efficacy of etanercept in refractory enthesitis-related arthritis","volume":"31","author":"Henrickson","year":"2004","journal-title":"J\u00a0Rheumatol"},{"issue":"1","key":"10.1016\/j.pcl.2012.03.014_bib77","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.jbspin.2008.03.008","article-title":"Efficacy and safety of TNFalpha antagonist therapy in patients with juvenile spondyloarthropathies","volume":"76","author":"Sulpice","year":"2009","journal-title":"Joint Bone Spine"},{"issue":"7","key":"10.1016\/j.pcl.2012.03.014_bib78","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1002\/art.21121","article-title":"Anti-tumor necrosis factor alpha blockade in the treatment of juvenile spondylarthropathy","volume":"52","author":"Tse","year":"2005","journal-title":"Arthritis Rheum"},{"issue":"10","key":"10.1016\/j.pcl.2012.03.014_bib79","doi-asserted-by":"crossref","first-page":"2258","DOI":"10.3899\/jrheum.110145","article-title":"Tumor necrosis factor-blocking agents for children with enthesitis-related arthritis\u2013data from the Dutch Arthritis and Biologicals in Children Register, 1999-2010","volume":"38","author":"Otten","year":"2011","journal-title":"J\u00a0Rheumatol"},{"issue":"4","key":"10.1016\/j.pcl.2012.03.014_bib80","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1002\/acr.20460","article-title":"2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: initiation and safety monitoring of therapeutic agents for the treatment of arthritis and systemic features","volume":"63","author":"Beukelman","year":"2011","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"7","key":"10.1016\/j.pcl.2012.03.014_bib81","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1136\/ard.2008.101030","article-title":"When and how to stop etanercept after successful treatment of patients with juvenile idiopathic arthritis","volume":"68","author":"Prince","year":"2009","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"10.1016\/j.pcl.2012.03.014_bib82","doi-asserted-by":"crossref","first-page":"3096","DOI":"10.1002\/art.22838","article-title":"A\u00a0randomized, placebo-controlled trial of infliximab plus methotrexate for the treatment of polyarticular-course juvenile rheumatoid arthritis","volume":"56","author":"Ruperto","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.pcl.2012.03.014_bib83","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1136\/ard.2009.100354","article-title":"Long-term efficacy and safety of infliximab plus methotrexate for the treatment of polyarticular course juvenile rheumatoid arthritis: findings from an open-label treatment extension","volume":"69","author":"Ruperto","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.pcl.2012.03.014_bib84","first-page":"745","article-title":"A\u00a03-month, double-blind, placebo-controlled, randomized trial of infliximab in juvenile-onset spondyloarthritis (SpA) and a 52-week open extension","volume":"26","author":"Burgos-Vargas","year":"2008","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.pcl.2012.03.014_bib85","first-page":"319","article-title":"Efficacy, safety, and tolerability of Infliximab in Juvenile-onset Spondyloarthropathies (JO-SpA): results of the three month, randomized, double-blind, placebo-controlled trial phase","volume":"56","author":"Burgos-Vargas","year":"2007","journal-title":"Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.pcl.2012.03.014_bib86","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s00296-003-0378-0","article-title":"Infliximab in two patients with juvenile ankylosing spondylitis","volume":"24","author":"Schmeling","year":"2004","journal-title":"Rheumatol Int"},{"issue":"6","key":"10.1016\/j.pcl.2012.03.014_bib87","first-page":"1186","article-title":"Radiologic Improvement of juvenile idiopathic arthritis-enthesitis-related arthritis following anti-tumor necrosis factor-alpha blockade with etanercept","volume":"33","author":"Tse","year":"2006","journal-title":"J\u00a0Rheumatol"},{"issue":"8","key":"10.1016\/j.pcl.2012.03.014_bib88","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1056\/NEJMoa0706290","article-title":"Adalimumab with or without methotrexate in juvenile rheumatoid arthritis","volume":"359","author":"Lovell","year":"2008","journal-title":"N\u00a0Engl J Med"},{"issue":"8","key":"10.1016\/j.pcl.2012.03.014_bib89","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1007\/s10067-009-1162-7","article-title":"Use of adalimumab in patients with juvenile idiopathic arthritis refractory to etanercept and\/or infliximab","volume":"28","author":"Katsicas","year":"2009","journal-title":"Clin Rheumatol"},{"issue":"2","key":"10.1016\/j.pcl.2012.03.014_bib90","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1002\/art.30128","article-title":"Anakinra as first-line disease modifying therapy in systemic juvenile idiopathic arthritis","volume":"63","author":"Nigrovic","year":"2011","journal-title":"Arthritis Rheum"},{"issue":"5","key":"10.1016\/j.pcl.2012.03.014_bib91","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1136\/ard.2010.134254","article-title":"A\u00a0multicentre, randomised, double-blind, placebo-controlled trial with the interleukin-1 receptor antagonist anakinra in patients with systemic-onset juvenile idiopathic arthritis (ANAJIS trial)","volume":"70","author":"Quartier","year":"2011","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"10.1016\/j.pcl.2012.03.014_bib92","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1002\/art.23437","article-title":"The pattern of response to anti-interleukin-1 treatment distinguishes two subsets of patients with systemic-onset juvenile idiopathic arthritis","volume":"58","author":"Gattorno","year":"2008","journal-title":"Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.pcl.2012.03.014_bib93","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1002\/art.33342","article-title":"A\u00a0phase II study to evaluate dosing and preliminary safety and efficacy of canakinumab in systemic juvenile idiopathic arthritis with active systemic features","volume":"64","author":"Ruperto","year":"2012","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.pcl.2012.03.014_bib94","first-page":"S515","article-title":"Preliminary evidence for sustained bioactivity of IL-1 Trap (rilonacept), a long acting IL-1 inhibitor, in systemic juvenile idiopathic arthritis (SJIA)","volume":"56","author":"Lovell","year":"2007","journal-title":"Arthritis Rheum"},{"issue":"9617","key":"10.1016\/j.pcl.2012.03.014_bib95","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/S0140-6736(08)60454-7","article-title":"Efficacy and safety of tocilizumab in patients with systemic-onset juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled, withdrawal phase III trial","volume":"371","author":"Yokota","year":"2008","journal-title":"Lancet"},{"issue":"9636","key":"10.1016\/j.pcl.2012.03.014_bib96","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0140-6736(08)60998-8","article-title":"Abatacept in children with juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled withdrawal trial","volume":"372","author":"Ruperto","year":"2008","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.pcl.2012.03.014_bib97","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1002\/art.27431","article-title":"Long-term safety and efficacy of abatacept in children with juvenile idiopathic arthritis","volume":"62","author":"Ruperto","year":"2010","journal-title":"Arthritis Rheum"},{"issue":"11","key":"10.1016\/j.pcl.2012.03.014_bib98","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1002\/acr.20283","article-title":"Abatacept improves health-related quality of life, pain, sleep quality, and daily participation in subjects with juvenile idiopathic arthritis","volume":"62","author":"Ruperto","year":"2010","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"9","key":"10.1016\/j.pcl.2012.03.014_bib99","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1007\/s10067-011-1720-7","article-title":"Efficacy and safety of repeat courses of rituximab treatment in patients with severe refractory juvenile idiopathic arthritis","volume":"30","author":"Alexeeva","year":"2011","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.pcl.2012.03.014_bib100","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/1546-0096-8-23","article-title":"Guilt by association\u2013what is the true risk of malignancy\u00a0in children treated with etanercept for JIA?","volume":"8","author":"Cron","year":"2010","journal-title":"Pediatr Rheumatol Online J"},{"issue":"1","key":"10.1016\/j.pcl.2012.03.014_bib101","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1093\/rheumatology\/keq361","article-title":"Report on malignancies in the German juvenile idiopathic arthritis registry","volume":"50","author":"Horneff","year":"2011","journal-title":"Rheumatology (Oxford)"},{"issue":"12","key":"10.1016\/j.pcl.2012.03.014_bib102","doi-asserted-by":"crossref","first-page":"3776","DOI":"10.1002\/art.27741","article-title":"Juvenile idiopathic arthritis and risk of cancer: a nationwide cohort study","volume":"62","author":"Simard","year":"2010","journal-title":"Arthritis Rheum"},{"issue":"9","key":"10.1016\/j.pcl.2012.03.014_bib103","doi-asserted-by":"crossref","first-page":"2809","DOI":"10.1002\/art.30426","article-title":"Ongoing disease activity and changing categories in a long-term nordic cohort study of juvenile idiopathic arthritis","volume":"63","author":"Nordal","year":"2011","journal-title":"Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.pcl.2012.03.014_bib104","first-page":"579","article-title":"Remission in juvenile chronic arthritis: a cohort study of 683 consecutive cases with a mean 10 year followup","volume":"30","author":"Fantini","year":"2003","journal-title":"J\u00a0Rheumatol"},{"issue":"9","key":"10.1016\/j.pcl.2012.03.014_bib105","doi-asserted-by":"crossref","first-page":"2392","DOI":"10.1002\/art.10444","article-title":"Long-term outcome in patients with juvenile idiopathic arthritis","volume":"46","author":"Minden","year":"2002","journal-title":"Arthritis Rheum"},{"issue":"12","key":"10.1016\/j.pcl.2012.03.014_bib106","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1093\/rheumatology\/41.12.1428","article-title":"Long-term follow-up of 246 adults with juvenile idiopathic arthritis: functional outcome","volume":"41","author":"Packham","year":"2002","journal-title":"Rheumatology (Oxford)"},{"issue":"2","key":"10.1016\/j.pcl.2012.03.014_bib107","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1093\/rheumatology\/39.2.198","article-title":"Juvenile chronic arthritis into adulthood: a long-term follow-up study","volume":"39","author":"Zak","year":"2000","journal-title":"Rheumatology (Oxford)"},{"issue":"13","key":"10.1016\/j.pcl.2012.03.014_bib108","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1001\/jama.294.13.1671","article-title":"Medical treatment of juvenile idiopathic arthritis","volume":"294","author":"Hashkes","year":"2005","journal-title":"JAMA"}],"container-title":["Pediatric Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031395512000156?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031395512000156?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,1,14]],"date-time":"2022-01-14T21:36:53Z","timestamp":1642196213000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0031395512000156"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4]]},"references-count":108,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,4]]}},"alternative-id":["S0031395512000156"],"URL":"https:\/\/doi.org\/10.1016\/j.pcl.2012.03.014","relation":{},"ISSN":["0031-3955"],"issn-type":[{"value":"0031-3955","type":"print"}],"subject":[],"published":{"date-parts":[[2012,4]]}}}